NeueHealth (NEUE) Competitors

$6.38
+0.09 (+1.43%)
(As of 04/30/2024 ET)

NEUE vs. BHG, NSPR, IMRX, BLRX, GANX, HSAQ, ZEPP, SCYX, VNRX, and RBOT

Should you be buying NeueHealth stock or one of its competitors? The main competitors of NeueHealth include Bright Health Group (BHG), InspireMD (NSPR), Immuneering (IMRX), BioLineRx (BLRX), Gain Therapeutics (GANX), Health Sciences Acquisitions Co. 2 (HSAQ), Zepp Health (ZEPP), SCYNEXIS (SCYX), VolitionRx (VNRX), and Vicarious Surgical (RBOT). These companies are all part of the "medical" sector.

NeueHealth vs.

Bright Health Group (NYSE:BHG) and NeueHealth (NYSE:NEUE) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, community ranking, media sentiment, risk, profitability, earnings and institutional ownership.

Bright Health Group received 15 more outperform votes than NeueHealth when rated by MarketBeat users. Likewise, 30.00% of users gave Bright Health Group an outperform vote while only 0.00% of users gave NeueHealth an outperform vote.

CompanyUnderperformOutperform
Bright Health GroupOutperform Votes
15
30.00%
Underperform Votes
35
70.00%
NeueHealthOutperform Votes
No Votes
Underperform Votes
1
100.00%

Bright Health Group has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Comparatively, NeueHealth has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500.

NeueHealth has lower revenue, but higher earnings than Bright Health Group. NeueHealth is trading at a lower price-to-earnings ratio than Bright Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bright Health Group$2.76B0.02-$1.46B-$208.73-0.03
NeueHealth$1.16B0.05-$1.15B-$151.20-0.04

Bright Health Group currently has a consensus target price of $13.00, suggesting a potential upside of 103.68%. NeueHealth has a consensus target price of $8.00, suggesting a potential upside of 25.34%. Given NeueHealth's higher possible upside, research analysts clearly believe Bright Health Group is more favorable than NeueHealth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bright Health Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
NeueHealth
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

63.9% of NeueHealth shares are held by institutional investors. 58.4% of Bright Health Group shares are held by company insiders. Comparatively, 64.3% of NeueHealth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

NeueHealth has a net margin of -71.23% compared to NeueHealth's net margin of -85.40%.

Company Net Margins Return on Equity Return on Assets
Bright Health Group-85.40% N/A -10.26%
NeueHealth -71.23%N/A -1.21%

In the previous week, NeueHealth had 23 more articles in the media than Bright Health Group. MarketBeat recorded 23 mentions for NeueHealth and 0 mentions for Bright Health Group. NeueHealth's average media sentiment score of 0.88 beat Bright Health Group's score of -0.09 indicating that Bright Health Group is being referred to more favorably in the media.

Company Overall Sentiment
Bright Health Group Positive
NeueHealth Neutral

Summary

NeueHealth beats Bright Health Group on 9 of the 16 factors compared between the two stocks.

Get NeueHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEUE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NEUE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEUE vs. The Competition

MetricNeueHealthHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$52.46M$64.96B$4.85B$17.46B
Dividend YieldN/A1.37%2.83%3.53%
P/E Ratio-0.0413.55173.3620.98
Price / Sales0.050.492,364.1010.25
Price / Cash0.1010.1246.4415.46
Price / Book-0.043.364.714.86
Net Income-$1.15B$3.04B$102.39M$964.11M
7 Day Performance-1.20%-2.00%0.85%-0.78%
1 Month Performance1.29%-4.16%-6.44%-4.42%
1 Year PerformanceN/A3.90%4.31%94.31%

NeueHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BHG
Bright Health Group
0 of 5 stars
$6.31
+8.0%
$13.00
+106.0%
-50.4%$50.37M$2.76B-0.032,840Gap Up
NSPR
InspireMD
2.0613 of 5 stars
$2.12
-4.1%
$4.85
+128.8%
+86.5%$51.84M$6.21M-1.9665Gap Down
IMRX
Immuneering
4.1021 of 5 stars
$1.77
-4.8%
$13.50
+662.7%
-87.1%$51.83M$320,000.00-0.9468Upcoming Earnings
Short Interest ↓
BLRX
BioLineRx
1.3122 of 5 stars
$0.64
+3.2%
$21.00
+3,180.7%
-37.4%$51.17M$4.80M-0.7179Gap Up
GANX
Gain Therapeutics
3.0826 of 5 stars
$3.15
-0.9%
$8.33
+164.6%
-41.7%$51.09M$50,000.00-1.8428Short Interest ↑
Positive News
HSAQ
Health Sciences Acquisitions Co. 2
0 of 5 stars
$4.71
+1.9%
N/A-72.6%$52.81MN/A0.004
ZEPP
Zepp Health
3.0993 of 5 stars
$0.83
flat
$4.96
+497.4%
-42.5%$50.92M$351.46M-1.69987News Coverage
Positive News
SCYX
SCYNEXIS
2.1759 of 5 stars
$1.41
-0.7%
$15.00
+967.6%
-46.3%$53.04M$140.14M1.0629News Coverage
VNRX
VolitionRx
0 of 5 stars
$0.62
+3.3%
$2.50
+305.1%
N/A$50.65M$770,000.00-1.21110Upcoming Earnings
RBOT
Vicarious Surgical
1.458 of 5 stars
$0.29
+3.6%
$0.67
+131.9%
-86.8%$50.53MN/A-0.593News Coverage

Related Companies and Tools

This page (NYSE:NEUE) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners